EQ101 (formerly known as BNZ-1) is a synthetic peptide, designed to selectively inhibit IL-2, IL-9, and IL-15 binding to the common gamma chain (γc) signaling receptor, leading to the depletion of Tregs and tumor growth suppression [159]. Here, IL15 is linked to neoplasm.